arrow
V

Vincent Pellegrino

Alfred Health
H指数:36
被引数:7,883

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Population pharmacokinetics of caspofungin in critically ill patients receiving extracorporeal membrane oxygenation-an ASAP ECMO study

卡泊芬净在接受体外膜氧合的危重患者中的群体药代动力学-一项ASAP ECMO研究

2025-02-130
OAAI
Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation (vol 50, pg 1470, 2024)

静脉动脉体外膜氧合患者的保守或自由氧目标 (vol 50,pg 1470,2024)

2024-10-160
OAAI
Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation
2024-08-203
OAAI
Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study
2024-01-108
OA
Fulminant myocarditis proven by early biopsy and outcomes

早期活检证实的暴发性心肌炎和结果

2023-11-0611
OA
Antimicrobial Exposures in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation
2023-03-1522
PRE
Incidence of death or disability at 6 months after extracorporeal membrane oxygenation in Australia: a prospective, multicentre, registry-embedded cohort study
2022-11-0118
PRE
Reply Letter to the Editor Regarding the ELSO Interim Guidelines for Veno-Arterial Extracorporeal Membrane Oxygenation in Adult Cardiac Patients

给编辑的关于成人心脏病患者静脉动脉体外膜氧合的ELSO临时指南的回信

2022-03-181
OA
Population Pharmacokinetics of Piperacillin and Tazobactam in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: an ASAP ECMO Study
2021-10-1812
OA
ELSO Interim Guidelines for Venoarterial Extracorporeal Membrane Oxygenation in Adult Cardiac Patients

成人心脏病患者静脉动脉体外膜氧合的ELSO临时指南

2021-07-07229
OA